missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CY-09, MedChemExpress
Click to view available options
Quantity:
1 mg
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
1mg
50mg
5mg
Description
CY-09 is a selective and direct NLRP3 inhibitor. CY-09 directly binds to the ATP-binding motif of NLRP3 NACHT domain and inhibits NLRP3 ATPase activity, resulting in the suppression of NLRP3 inflammasome assembly and activation.
Specifications
Specifications
| Chemical Name or Material | CY-09 |
| Physical Form | Solid |
| CAS | 1073612-91-5 |
| Color | Yellow |
| Quantity | 5 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C19H12F3NO3S2 |
| For Use With (Application) | COVID-19-immunoregulation |
| Solubility Information | DMSO : ≥ 150 mg/mL (354.25 mM) ∣H2O : < 0.1 mg/mL (insoluble) |
| SMILES | OC(C1=CC=C(/C=C2SC(N(CC3=CC=CC(C(F)(F)F)=C3)C\2=O)=S)C=C1)=O |
| Show More |
Research purposes only
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction